Get the Stockscreener App
90.78
1.09%
-1.00
After Hours:
90.74
-0.04
-0.04%
Vaneck Pharmaceutical Etf stock is traded at $90.78, with a volume of 703.19K.
It is down -1.09% in the last 24 hours and up +7.09% over the past month.
See More
Previous Close:
$91.78
Open:
$90.79
24h Volume:
703.19K
Relative Volume:
1.59
Market Cap:
$907.13M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.66%
1M Performance:
+7.09%
6M Performance:
+3.37%
1Y Performance:
-1.25%
1-Day Range:
$90.49
$91.44
1-Week Range:
$88.89
$91.78
52-Week Range:
$77.67
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Name
Vaneck Pharmaceutical Etf
Sector
Industry
Phone
-
Address
-
Compare PPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
90.78 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
293.57 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
597.00 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
599.79 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
229.68 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
526.96 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Stock (PPH) Latest News
Millennium Management LLC Lowers Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Trump says pharma tariffs are coming in the “not-too-distant-future” - MSN
Ameriprise Financial Inc. Sells 3,806 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Ameriprise Financial Inc. Decreases Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
Innovator Growth-100 Power Buffer ETF – September (NYSEARCA:NSEP) Holdings Lifted by Jane Street Group LLC - Defense World
Invesco S&P 500 Pure Growth ETF (NYSEARCA:RPG) Stake Boosted by Ameriprise Financial Inc. - Defense World
D. E. Shaw & Co. Inc. Trims Stake in Vanguard S&P 500 Value ETF (NYSEARCA:VOOV) - Defense World
D. E. Shaw & Co. Inc. Has $363,000 Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
D. E. Shaw & Co. Inc. Decreases Holdings in SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Stake Raised by Bank of America Corp DE - Defense World
Bank of America Corp DE Purchases 1,732 Shares of VanEck Retail ETF (NASDAQ:RTH) - Defense World
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
Gilead and Vertex Pharma named among biotech’s tariff safe havens - MSN
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work - Inkl
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Comerica Bank - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Jane Street Group LLC - Defense World
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - TradingView
Do Wall Street Analysts Like Cencora Stock? - inkl
PPH, Big Pharma Stocks Volatile on Trump Drug Pricing - ETF.com
Stock ETFs Surge on China Tariffs Pact; Bonds, Gold Falter - Yahoo Finance
Biopharma Stocks Rise as Trump Orders Drug Price Cuts - Genetic Engineering and Biotechnology News
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - NewsBreak: Local News & Alerts
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks - Benzinga
A Look at Pharma ETFs After Strong Q1 Earnings - Yahoo Finance
Stock Traders Purchase High Volume of VanEck Pharmaceutical ETF Put Options (NASDAQ:PPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Well-Timed Bearish Drug ETF Bet Pays Off on Vaccine Chief News - Bloomberg.com
India proposes zero-for-zero tariff deal on U.S. auto parts, steelreport - Seeking Alpha
Envestnet Asset Management Inc. Has $499,000 Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Raymond James Financial Inc. Acquires New Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Bought by JPMorgan Chase & Co. - Defense World
Where to Invest $10,000 Right Now - Bloomberg.com
VanEck Pharmaceutical ETF Target of Unusually High Options Trading (NASDAQ:PPH) - Defense World
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Nasdaq
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike - TradingView
PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger (NASDAQ:PPH) - Seeking Alpha
StockWatch: Trump Tariffs Take Biopharma on a Roller Coaster Ride - Genetic Engineering and Biotechnology News
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
Pharma, MedTech stocks bounce back as Trump pauses most tariffs - Seeking Alpha
LPL Financial LLC Sells 35,154 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Trump says 'major tariff on pharmaceuticals' coming soon (PPH:NASDAQ) - Seeking Alpha
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now - Genetic Engineering and Biotechnology News
Vaneck Pharmaceutical Etf Stock (PPH) Financials Data
There is no financial data for Vaneck Pharmaceutical Etf (PPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):